Quick10K

⚲

EVERTEC

Filings

10-Q	2020-09-30	Filed 2020-10-30
10-Q	2020-06-30	Filed 2020-08-05
10-Q	2020-03-31	Filed 2020-05-11
10-K	2019-12-31	Filed 2020-02-27
10-Q	2019-09-30	Filed 2019-10-31
10-Q	2019-06-30	Filed 2019-08-02
10-Q	2019-03-31	Filed 2019-05-03
10-K	2018-12-31	Filed 2019-02-26
10-Q	2018-09-30	Filed 2018-10-31
10-Q	2018-06-30	Filed 2018-08-02
10-Q	2018-03-31	Filed 2018-05-03
10-K	2017-12-31	Filed 2018-02-28
10-Q	2017-09-30	Filed 2017-11-09
10-Q	2017-06-30	Filed 2017-08-03
10-Q	2017-03-31	Filed 2017-05-05
10-K	2016-12-31	Filed 2017-02-24
10-Q	2016-09-30	Filed 2016-11-03
10-Q	2016-06-30	Filed 2016-08-02
10-K	2016-03-31	Filed 2016-05-26
10-K	2015-12-31	Filed 2016-05-26
10-Q	2015-09-30	Filed 2015-11-06
10-Q	2015-06-30	Filed 2015-08-07
10-Q	2015-03-31	Filed 2015-05-11
10-K	2014-12-31	Filed 2015-03-02
10-Q	2014-09-30	Filed 2014-11-06
10-Q	2014-06-30	Filed 2014-08-07
10-Q	2014-03-31	Filed 2014-05-08
10-K	2013-12-31	Filed 2014-03-17
10-Q	2013-09-30	Filed 2013-11-07
10-Q	2013-06-30	Filed 2013-08-14
10-Q	2013-03-31	Filed 2013-05-15

Reports

8-K	2021-02-18	Regulation FD, Exhibits
8-K	2020-12-17	Other Events, Exhibits
8-K	2020-10-29
8-K	2020-10-20
8-K	2020-08-04
8-K	2020-07-24
8-K	2020-05-28
8-K	2020-05-08
8-K	2020-04-21
8-K	2020-02-25
8-K	2020-02-20
8-K	2019-10-30
8-K	2019-10-24
8-K	2019-07-31
8-K	2019-07-26
8-K	2019-05-24
8-K	2019-05-01
8-K	2019-04-25
8-K	2019-02-22
8-K	2019-02-20
8-K	2019-02-15
8-K	2018-12-21
8-K	2018-11-28
8-K	2018-11-08
8-K	2018-10-30
8-K	2018-10-26
8-K	2018-10-26
8-K	2018-08-07
8-K	2018-07-31
8-K	2018-07-26
8-K	2018-05-24
8-K	2018-05-02
8-K	2018-02-21

EVERTEC Financials

EVTC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546	323	0	0	0	0	-854
1 800 Flowers Com (FLWS)	944	42%	13.3	6%	665	336	1,266	534	37	75	1,001
10x Genomics (TXG)	4,805	75%	-490.3	-2%	573	151	61	46	-10	-9	4,357
12 Retech (RETC)	0	32%	-0.1	-1,385%	1	20	1	0	-15	-15	1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	34	0%	0.4	-5%	164	108	18	0	-8	-8	-3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	19	23	27	7	-3	-1	3
1895 Bancorp of Wisconsin (BCOW)	46,153		12,508.1	-0%	441	383	0	0	-0	4	46,142
1st Constitution Bancorp (FCCY)	165	0%	4.4	1%	1,343	1,204	0	0	14	33	144
1st Franklin Financial (FFC)	4		-0.6	7%	905	645	0	0	62	80	-46
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200		7.9	1%	6,691	5,858	0	0	70	136	1,073
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	2	0	0	-2	-2	0
21Vianet Group (VNET)	6,005			0%	11,151	5,788	0	0	0	0	3,344
22nd Century (XXII)	302	1%	-14.1	-36%	62	7	26	0	-22	-21	302
1Life Healthcare (ONEM)


Balance Sheet ($MM)	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	34	20	28	22	27	28	29	32	32	39	40	29	36	36	45	52	52	93	48	50	64	70	104	87	87	78	116
Accounts Receivable	75	78	69	68	68	71	69	76	79	71	68	74	75	72	67	78	77	77	76	83	90	82	83	100	96	94	92
Inventory
PP&E	35	33	32	79	80	82	86	90	92	99	104	108	111	116	121	117	119	117	121	107	110	121	121	122	136	131	130
Assets	974	947	935	919	906	900	890	890	886	880	883	870	870	864	867	886	883	915	905	903	917	904	929	927	969	950	980
Accounts Payable	23	26	15	19	12	14	15	23	19	19	22	21	20	18	27	41	27	32	28	41	41	35	37	47	46	35	25
Long-Term Debt	743	702	695	736	721	699	679	694	686	666	675	669	662	655	644	651	645	662	642	617	601	570	565	539	557	537	531
Liabilities	843	781	761	808	791	774	752	771	764	744	765	772	760	757	761	777	757	781	767	755	738	707	714	712	752	722	731
Stockholders' Equity	131	167	174	111	115	126	139	120	122	136	118	98	106	104	102	105	122	130	134	144	175	193	211	211	212	224	245


Income Statement ($MM)	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	87	89	87	93	87	91	89	94	91	93	93	96	95	98	94	47	101	104	103	43	110	113	112		119	123	119
Cost of Revenue			2	2	0	1	0	1	1	1	0	0	0	1	0	1	0	0	2	0	0	1
Gross Profit			86	92	87	91	89	94	91	93	92	96	95	97	94	46	101	103	101	43	110	112
R&D
SG&A	9	12	9	9	8	10	7	16	8	9	10	10	11	13	11	13	11	15	15	16	13	18	14		15	15	15
Tax	0	-5	1	2	2	3	1	2	2	2	2	-9	2	3	2	2	2	4	-5	2	4	4	3		4	7	4
Net Income	5	-65	15	20	18	21	19	12	19	20	13	33	19	20	20	16	23	20	6	6	23	20	23		27	27	25


Cash Flow ($MM)	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating	34	-48	28	49	30	38	36	-47	30	47	46	40	30	39	55	43	25	46	37	37	30	46	52		29	47	60
Cash Investing	-4	-8	-5	-12	-2	-7	-8	-9	-4	-12	-19	-18	-6	-15	-13	-20	-7	-9	-54	-9	-9	-6	-9		-14	-22	-14
Cash Financing	-21	41	-14	-43	-23	-30	-27	-24	-26	-29	-25	-34	-17	-24	-33	-16	-18	4	-28	-27	-17	-34	-9		-16	-34	-8